Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

131 results about "Genotoxic impurities" patented technology

A method for determining genotoxic impurities in urapidil hydrochloride raw material

The invention discloses a method for detecting a genotoxic impurity 6-[[3-(2-methoxyphenylamino)propyl]amino]-1,3-dimethyluracil in an urapidil hydrochloride raw material medicine. The method has good separation, strong specificity, high sensitivity and good accuracy, and can control the genotoxic impurity 6-[[3-(2-methoxyphenylamino)propyl]amino]-1,3-dimethyluracil in the urapidil hydrochloride raw material medicine, thereby ensuring the quality of a final product and the safety of medication.
Owner:SHANDONG LUOXIN PHARMA GRP CO LTD +2

Method for analyzing N-nitrosodiclofenac genotoxic impurity content in chemical medicine

The invention belongs to the technical field of analysis and detection, and particularly relates to a method for analyzing the content of N-nitrosodiclofenac genotoxic impurities in chemical drugs. According to the analysis method, the content of the N-nitrosodiclofenac impurity in the chemical medicine is measured by utilizing a triple four-stage liquid chromatograph-mass spectrometer, and the content of the N-nitrosodiclofenac impurity is analyzed by taking a 50vol% acetonitrile aqueous solution (containing 0.1 vol% formic acid) as a solvent and dichloromethane as an extracting agent and utilizing a standard curve method. The problems that the impurity limit is low, the matrix of the test sample is complex and easy to interfere, the structure of the impurity is similar to the main component of the test sample and false positive is easily caused are solved by dissolving the test sample with a solvent and then extracting with an extracting agent, and meanwhile, the sensitivity of the N-nitrosodiclofenac impurity is improved by adopting a high performance liquid chromatography-mass spectrometry method. The detection method is efficient and accurate.
Owner:ZIBO HIGH TECH IND DEV ZONE BIOMEDICAL RES INST

Process for the preparation of mirabegron free from genotoxic impurities

The present invention relates to mirabegron substantially free from genotoxic impurities particularly nitrosamine impurities of Formula (I), (II), (III), (IV), (V) and processes for its preparation. In particular, the invention relates to processes for the preparation of high purity mirabegron free from nitrosamine impurities of Formula (I), (II), (III), (IV), (V) and other genotoxic and carcinogenic impurities below threshold concentration.
Owner:ZYDUS LIFESCIENCES LTD

A method for detecting genotoxic impurities in vortioxetine hydrobromide orally disintegrating tablets and its application

The invention discloses a method for detecting genotoxic impurities in vortioxetine hydrobromide orally disintegrating tablets. The method comprises the following steps: mixing phosphate buffer and methanol, wherein the volume ratio of the phosphate buffer to the methanol is 1-20:80-100, to obtain a solvent; grinding the vortioxetine hydrobromide orally disintegrating tablets, adding the mixture into the solvent for dissolution, filtering, and obtaining a test solution; then detecting the test solution by an HPLC method to obtain the content of the genotoxic impurities in the flutioxetine hydrobromide orally disintegrating tablets; the structural formula of the genotoxic impurities is shown in formula (I): The detection method of the invention has accurate and reliable results, is simple and convenient to operate, is rapid, has high stability, good repeatability and durability, can effectively break the difference between solubility and stability, has a recovery rate close to 100%, and has no significant degradation trend of nitrosamine impurities.
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV

Detection method of rupatadine fumarate genotoxic impurities

The invention relates to a method for detecting genotoxic impurities of rupatadine fumarate, which is characterized in that a phosphate buffer solution is matched with acetonitrile, a high performance liquid chromatography method is adopted, a chromatographic column is a silica gel bonded octadecylsilane column, a gradient program is adopted for elution, and the content of the rupatadine fumarate genotoxic impurities in the rupatadine fumarate genotoxic impurities in the rupatadine fumarate genotoxic impurities is detected. Effective separation between rupatadine fumarate and genotoxic impurities and between genotoxic impurities can be achieved, accurate quantitative analysis can be achieved, and the quality of drugs can be effectively controlled.
Owner:AVENTIS PHARMA HAINAN

Method for detecting two potential genotoxic impurities in carbon [13C]-urea based on gas chromatography

The invention belongs to the technical field of pharmaceutical analysis, and discloses a method for determining two potential genotoxic impurities in carbon [13C]-urea by gas chromatography. Comprising the following steps: (1) preparing a sample solution; (2) preparing a reference solution; (3) taking nitrogen as carrier gas, and detecting by adopting a medium-polarity or weak-polarity chromatographic column separation system; and (4) calculating by a peak area through an external standard method to obtain the accurate contents of methyl carbamate and ethyl carbamate in the carbon [13C]-urea. The method disclosed by the invention is simple to operate, good in specificity, linearity, precision and accuracy and high in sensitivity, and can realize accurate detection of residual potential genotoxic impurities, namely methyl carbamate and ethyl carbamate, in the carbon [13C]-urea.
Owner:VERIZON BIOTECHNOLOGY (KUNSHAN) CO LTD

Detection method of L-alanine isopropyl ester in emtricitabine, propiophenol and tenofovir tablet

PendingCN121453970AComponent separationEmtricitabineGradient elution
The invention relates to the technical field of pharmaceutical analysis, and particularly discloses a high performance liquid chromatography-mass spectrometry tandem method (HPLC-MS / MS) for detecting a genotoxic impurity L-alanine isopropyl ester in an emtricitabine-propofol tenofovir tablet. By optimizing chromatographic column selection, a mobile phase gradient elution procedure and mass spectrometric detection parameters, the method realizes exclusive, sensitive and accurate detection of the L-isopropyl alanine. The methodological verification result shows that the detection limit is 1.00 ng / mL, the quantification limit is 2.00 ng / mL, the linear range is 2.00-100.00 ng / mL (the correlation coefficient r is equal to 0.9994), the recovery rate is stabilized between 92% and 98%, and the precision and repeatability are good. The detection method has the advantages of high sensitivity and strong selectivity, is suitable for quality control of emtricitabine propofol tenofovir tablets, meets the control requirements of ICH M7 guide on genotoxic impurities, and has good practicability and popularization value.
Owner:SHANDONG BOJI MEDICAL TECH CO LTD

Voriconazole dry suspension as well as preparation process, medical application and detection method thereof

The invention discloses a voriconazole dry suspension as well as a preparation process, medical application and a detection method thereof. The voriconazole dry suspension is prepared from voriconazole and cane sugar, wherein the particle size D10 of the sucrose is 1-8 [mu] m, the particle size D50 of the sucrose is 9-40 [mu] m, and the particle size D90 of the sucrose is 30-120 [mu] m; the particle size D10 of the voriconazole dry suspension is 10 to 70 [mu] m, the particle size D50 of the voriconazole dry suspension is 50 to 300 [mu] m, and the particle size D90 of the voriconazole dry suspension is 150 to 500 [mu] m. The voriconazole dry suspension provided by the invention has excellent stability, is still low in genotoxic impurities after long-term storage, can be suitable for normal-temperature transportation, storage and use, reduces the transportation and storage cost, and improves the use convenience of patients.
Owner:SHANGHAI ZHONGXI PHARMACEUTICAL CO LTD

A cimetidine injection composition and a production process thereof

PendingCN123024037ANitrosoIrritation
The application provides a cimetidine injection composition and a production process thereof, and belongs to the technical field of pharmaceutical preparations, and solves the technical problems of complex prescription, strong sensitization of auxiliary materials, strong irritation and insufficient control of genotoxic impurities of the existing cimetidine injection. The cimetidine injection composition and the production process thereof, the composition is composed of cimetidine, hydrochloric acid solution, sodium chloride and water for injection, the pH value is 5.0-6.8, the molar concentration of osmotic pressure is 280-320 mOsmol / kg, and 0.2 g of cimetidine is contained in every 2 ml. The application replaces the antioxidant by full nitrogen protection, establishes a high-sensitivity LC-MS / MS method for detecting N-nitroso cimetidine, and shows that the muscle irritation of non-clinical safety is better than that of the commercial preparation, the allergic and hemolytic reactions are both negative, the cytotoxicity is 0-1 level, and the unification of prescription simplification, safety improvement and quality control is realized.
Owner:FUJIAN GUTIAN PHARMA

Detection method of genotoxic impurities and application thereof

The invention discloses a genotoxic impurity detection method, which can simultaneously detect genotoxic impurities NDMA, NDPA and dimethyl sulfate, adopts a gas chromatography-mass spectrometry (GC-MS) technology, dissolves a sample through a formic acid-containing anhydrous / ultra-dry organic solvent, and combines chromatography-mass spectrometry conditions to realize efficient and synchronous detection of the three impurities. The chromatographic conditions are simple, the mass spectrum detection limit is excellent, the impurity stability is remarkably improved by the method, and the recovery rate RSD value is 1t; the method is good in detection specificity and high in precision, so that the genotoxic impurities in the medicine are effectively controlled, the quality of the medicine is guaranteed, the safety of clinical medication is further guaranteed, and the method has remarkable technical advantages and industrial application value.
Owner:BEIJING TIDE PHARMACEUTICAL CO LTD

Method for detecting genotoxic impurities in lamotrigine

The invention relates to the technical field of drug analysis and detection, and particularly discloses a method for detecting genotoxic impurities in lamotrigine. According to the method for detecting the genotoxic impurities in the lamotrigine, a Venusil XBP C18 (L) (150mm * 4.6 mm, 5mu m) chromatographic column is adopted, a mixed solution of a monopotassium phosphate solution-triethylamine and a mixed solution of acetonitrile are used as a mobile phase, and the genotoxic impurities (impurities K) in the lamotrigine are accurately detected in a gradient elution mode through a high performance liquid chromatography method. The detection limit of the impurity K is 0.0013 mu g / mL, the quantification limit is 0.0025 mu g / mL, and the detection requirements of the guiding principle of ICH M7 are met. The method provided by the invention has the advantages of strong specificity, high sensitivity, good linear relationship, good precision and durability, and can be used as a basis for monitoring the quality of lamotrigine drugs.
Owner:RENHE YIKANG CHUANGYI PHARMACEUTICAL HEBEI CO LTD +2

Method for detecting N-nitrosoimino diacetic acid in vortioxetine hydrobromide

The invention relates to a method for detecting N-nitrosoimino diacetic acid in vortioxetine hydrobromide, which adopts an ion chromatography method, adopts a chromatographic column taking polystyrene-divinylbenzene copolymer as a filler, and adopts a mixed solution of sodium carbonate and sodium bicarbonate as a leacheate. The method disclosed by the invention is simple, good in specificity, accuracy and sensitivity, and beneficial to control on the content of genotoxic impurities in the hydrobromic acid vortioxetine.
Owner:YAOPHARMA CO LTD

Method for determining contents of seven genotoxic impurities in epichlorohydrin by gas chromatography-mass spectrometry

The invention discloses a method for determining the content of seven genotoxic impurities in epichlorohydrin through gas chromatography-mass spectrometry, and belongs to the technical field of pharmaceutical analysis. According to the method, a quartz capillary chromatographic column taking polyethylene glycol as a stationary phase is adopted, split-flow sample injection is performed, and the genotoxic impurities in an epoxy chloropropane sample are detected by using a gas chromatography-mass spectrometry method; the genetic toxicity impurities are glycidyl, 1, 3-dichloro-2-propyl alcohol, 2, 3-dichloro-1-propyl alcohol, 3-chloro-1, 2-propylene glycol, 2-chloro-1, 3-propylene glycol, 2-chloro-2-propylene-1-alcohol, and 1, 2, 3-trichloropropane. The invention further discloses a preparation method of the compound. According to the present invention, the seven genotoxic impurities in the epoxy chloropropane can be rapidly, effectively, accurately and reliably separated and detected, and the genotoxic impurities can be controlled within the low detection range through the mass spectrometer, such that the quality of the epoxy chloropropane can be easily controlled, the product quality of the hexyl aminolevulinate hydrochloride can be easily improved, and the medication safety of the patient can be easily improved.
Owner:JIANGSU LIANHUAN PHARMA

HPLC (High Performance Liquid Chromatography) detection method for sulfonate impurities in calcium dobesilate

The invention provides an HPLC (High Performance Liquid Chromatography) detection method for sulfonate impurities in calcium dobesilate, and relates to the field of medicine detection. Comprising the following steps: a chromatographic column is an octadecyl silane bonded silica gel chromatographic column; mobile phases: taking an ammonium dihydrogen phosphate solution as a mobile phase A and methanol as a mobile phase B; the elution mode is as follows: gradient elution is carried out, the adjustment range of the mobile phase A is 80-60% v / v, and the adjustment range of the mobile phase B is 20-40% v / v. By adopting the HPLC detection method disclosed by the invention, the contents of three genotoxic impurities, namely methyl 2, 5-dihydroxybenzenesulfonate, ethyl 2, 5-dihydroxybenzenesulfonate and isopropyl 2, 5-dihydroxybenzenesulfonate, in the calcium dobesilate raw material medicine are effectively determined, the sensitivity is high, the quantitation limit is low, the quality of the calcium dobesilate raw material medicine is better controlled, and the medicine safety is better guaranteed. On the premise that the detection effect is guaranteed, the detection method is simple and easy to operate, the detection cost is effectively reduced, and an impurity control scheme which is more economical, stable and easy to popularize is achieved.
Owner:HAINAN LINHENG PHARMA

Method for detecting benzyl bromide analogue impurities in alogliptin benzoate raw material medicine

The invention discloses a method for detecting benzyl bromide analogue impurities in an alogliptin benzoate raw material medicine, and relates to the technical field of medicine analysis and detection. According to the method, one-time detection of the three benzyl bromide analogue impurities in the alogliptin benzoate raw material medicine can be achieved, the detection sensitivity can reach the ppm (1 / million) level, and control over potential genotoxic impurities in the medicine can be better and more accurately achieved.
Owner:HEFEI TOPWAY BIOTECHNOLOGY CO LTD

High performance liquid chromatography detection method for trace genotoxic impurities in chlorpheniramine maleate

The invention discloses a high performance liquid chromatography detection method for trace genotoxic impurities in chlorpheniramine maleate, and belongs to the technical field of pharmaceutical analysis. According to the method, a chromatographic column taking octadecyl bonded silica gel as a filling agent is adopted, an ammonia water solution is taken as a mobile phase A, acetonitrile is taken as a mobile phase B, gradient elution is carried out, and genotoxic impurities in a chlorpheniramine maleate sample are detected by utilizing a high performance liquid chromatography; and the genotoxic impurities are 2-aminopyridine-N-oxide, 2-bromopyridine-N-oxide and 2-aminopyridine. The invention further discloses a preparation method of the genotoxic impurities. The method disclosed by the invention can be used for simultaneously detecting three trace genotoxic impurities, is high in sensitivity, good in separation degree and low in product matrix interference, can be widely applied to a high performance liquid chromatography detection method for determining the trace genotoxic impurities in the chlorpheniramine maleate, fully meets the qualitative and quantitative analysis of the trace genotoxic impurities in the product, and has a wide application prospect. And the product quality is effectively controlled.
Owner:南京联智医药科技有限公司

A method for detecting related substances in rifampicin and its application in MNP monitoring

The present invention relates to the field of drug detection, and in particular to a method for detecting related substances in rifampicin and its application in MNP monitoring. The method provided by the present invention comprises: preparing a test solution and a control solution, determining the content of rifampicin and related substances in rifampicin by high performance liquid chromatography, using quinone rifampicin as a pointer impurity, and monitoring the content of the genetic toxic impurity MNP of rifampicin by high performance liquid chromatography; the stationary phase adopts a C8 chromatographic column; the mobile phase A is a solution containing potassium dihydrogen phosphate and citric acid, and the mobile phase B contains methanol and acetonitrile. While the method of the present invention better detects rifampicin related substances, it can also monitor the content of MNP, reduce the risk of MNP exceeding the standard and improve the inspection efficiency.
Owner:NAT INST FOR FOOD & DRUG CONTROL

A method for analyzing genotoxic impurities in sulbactam sodium raw material

The invention discloses an analysis method for a genotoxic impurity (2S)-2-amino-3-ethoxysulfinyl-3-methylbutyric acid in a sulbactam sodium raw material. The analysis method has strong specificity and high sensitivity, and can be used for monitoring the target product of the synthesis method of the invention, and can also be used alone for detecting the genotoxic impurity (2S)-2-amino-3-ethoxysulfinyl-3-methylbutyric acid in the sulbactam sodium raw material, thereby ensuring the safety of the drug. The reaction raw materials of the synthesis method of the impurity are simple and easy to obtain, and the reaction is carried out in only one step, and the operation is simple.
Owner:SHANDONG LUOXIN PHARMA GRP CO LTD +2

A method for simultaneously detecting multiple genotoxic impurities in drugs

The present invention provides a method for simultaneously detecting multiple genotoxic impurities in a drug, wherein the genotoxic impurities are selected from one or more of budesonide triene impurity 5 (IM-5) of structural formula I and budesonide triene impurity 6 (IM-6) of structural formula II: wherein the method is liquid chromatography, and the liquid chromatography comprises the following chromatographic conditions: chromatographic column: a liquid chromatography column with core-shell octylsilane as a stationary phase; detection wavelength: 238-242nm; mobile phase A: 0.1v / v% phosphoric acid solution; mobile phase B: acetonitrile. The method of the present invention has good separation; no interference; strong specificity; high sensitivity; good linear relationship, can realize effective control of impurities in budesonide triene, and further ensures the product quality of budesonide and the drug safety of patients.
Owner:SHANGHAI FANGYU HEALTH PHARMA TECH CO LTD

Pyrroloyl piperidylamine compound and method for detecting genotoxic impurities of pyrroloyl piperidylamine compound

The invention belongs to the technical field of medical analysis, and discloses a pyrrole acyl piperidylamine compound and a method for detecting genotoxic impurities of the pyrrole acyl piperidylamine compound. Specifically, the invention relates to analysis and limit determination of four genotoxic impurities in a pyrroloyl piperidylamine new drug (code name compound 1) for resisting drug-resistant bacterium infection. According to the method, a liquid chromatography-mass spectrometry technology is adopted, octadecyl bonded silica gel is used as a stationary phase, a mixed solution of methanol and an ammonium acetate acidic aqueous solution is used as a mobile phase, and triple quadrupole mass spectrometry is used as a detector for analysis and determination. The genotoxic impurities comprise halogenated alkanes, halogenated olefins, carbamates and azo oxides. The method has relatively good specificity and sensitivity, can be used for accurately and quantitatively determining the genotoxic impurities, and is simple and rapid to operate. The method provides a method basis for quality control of the compound 1, and has important application value for quality control and safety guarantee in a new drug research and development process.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Method for purifying rifampicin from nitrosamine

The present invention relates to the control of the amount of genotoxic impurities in rifampicin, in particular the control of the amount of nitrosamines. In particular, the present invention relates to a process for the preparation of rifampicin that is substantially free of 1-methyl-4-nitrosopiperazine (MeNP) impurities. The present invention also relates to rifampicin that is substantially free of 1-methyl-4-nitrosopiperazine (MeNP) impurities.
Owner:OLON SPA

Method for determining genotoxic impurities of sucrose octasulfate potassium salt

PendingCN119064482Areliable referenceefficient separationComponent separationSucroseSilanes
The invention provides a method for determining genotoxic impurities of sucrose octasulfate potassium salt, and particularly relates to the field of medicines. Octadecylsilane chemically bonded silica is used as a filler, a 0.1% triethylamine aqueous solution is used as a mobile phase A, and acetonitrile is used as a mobile phase B; carrying out isocratic elution on the mobile phase A and the mobile phase B in a ratio of 85: 15; the column temperature is 43-47 DEG C, the flow velocity is 1.1-1.3 ml / min, the wavelength is 252-256 nm, the sample size is 15-25 [mu] l, and the operation time is 8-12 min; taking a proper amount of pyridine N oxide and 2-methylpyridine N oxide to prepare a reference substance solution containing 0.0004 mg per 1 ml, taking 20 [mu] 1 of the reference substance solution, injecting the reference substance solution into a liquid chromatograph, and recording a chromatogram; the method comprises the following steps: taking 200mg of a to-be-detected sample, precisely weighing, placing in a 10ml measuring flask, adding a diluent for dissolving and diluting to a scale, and uniformly shaking to obtain a test solution; precisely measuring 20 microliters of the test solution and 20 microliters of the reference solution, injecting the test solution and the reference solution into a liquid chromatograph, and recording chromatograms; the method provided by the invention can effectively separate and accurately analyze each impurity, has strong specificity and good separation degree, and can effectively control the product quality.
Owner:JIANGSU SKYRUN PHARMA CO LTD

A method for detecting genotoxic impurities in fosfomycin calcium

PendingCN122330306APhosphonomycinDiethyl phosphate
This invention discloses a method for detecting genotoxic impurities in fosfomycin calcium. The method involves preparing a test solution and a reference solution using hydrochloric acid as a solvent, and then detecting the test solution and reference solution using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS / MS) to obtain the content of genotoxic impurities in fosfomycin calcium. The genotoxic impurities are: 1,2-epoxypropyl diethyl phosphate, (2-propenyl)-diethyl phosphate, allyl diethyl phosphate, and propyl diethyl phosphate. This invention develops an analytical method capable of simultaneously detecting four diethyl phosphonate genotoxic impurities in fosfomycin calcium. This method exhibits good specificity, injection precision, linear range, limit of quantitation, limit of detection, accuracy, repeatability, intermediate precision, and robustness. It can be used for the detection and monitoring of diethyl phosphonate impurities in fosfomycin calcium raw materials, ensuring product quality and improving the safety of clinical medication.
Owner:BEIJING MINGZE ZHONGHE PHARM RES CO LTD

Method for detecting impurities in tadalafil bulk drug and / or tadalafil intermediate

The invention belongs to the technical field of analysis and detection, and discloses a method for detecting impurities in a tadalafil bulk drug and / or a tadalafil intermediate. The method for detecting the impurities in the tadalafil bulk drug and / or the tadalafil intermediate comprises the following steps: taking the tadalafil bulk drug and / or the tadalafil intermediate to be detected, and preparing a sample solution; taking an impurity standard substance, and preparing a standard sample solution; and detecting the impurities in the sample solution by adopting an ultra-high performance liquid chromatography-mass spectrometry method. According to the detection method, two N-nitroso genotoxic impurities and ten other process impurities in tadalafil raw materials and / or tadalafil intermediates can be determined at the same time, the specificity is high, the sensitivity is high, results of multiple different types of impurities can be obtained at the same time in one-time determination, the analysis efficiency is effectively improved, and the method is suitable for popularization and application. Powerful guarantee is provided for analyzing generation factors influencing impurities, effectively controlling medicine quality and guaranteeing medicine use safety.
Owner:GUANGDONG INST FOR DRUG CONTROL (GUANGDONG INST FOR DRUG QUALITY GUANGDONG PORT DRUG CONTROL INST)

Method for detecting genotoxic impurities in viloxin hydrochloride

The invention relates to a method for detecting genotoxic impurities in viloxin hydrochloride, in particular to a method for detecting the genotoxic impurities 2-hydroxymethyl morpholine-4-toluenesulfonate or hydrochloride thereof in the viloxin hydrochloride by adopting a UPLC-MS (Ultra Performance Liquid Chromatography-Mass Spectrometry) method. The method provided by the invention is good in system durability, high in separation degree and good in detection accuracy, and effectively solves the problem that genotoxic impurities in the viloxin hydrochloride are difficult to separate and the content of the genotoxic impurities in the viloxin hydrochloride is difficult to detect.
Owner:SUZHOU NHWA PHARM RES CO LTD +1

Method for detecting genotoxic impurities in dabigatran etexilate mesylate

The invention discloses a method for detecting genotoxic impurities in dabigatran etexilate mesylate, and belongs to the technical field of pharmaceutical analysis. The detection method comprises the following steps: pretreatment of a sample: dissolving a dabigatran etexilate mesylate sample in an acid solution, extracting, then centrifuging the extract liquor, and taking supernate to respectively obtain to-be-detected solutions; the method comprises the following steps: pre-treating a genotoxic impurity standard substance according to a method which is the same as a method for pre-treating a dabigatran etexilate mesylate sample to obtain a standard solution; and measuring the standard solution and the to-be-measured solution by adopting a gas chromatograph-tandem mass spectrometer, and calculating according to the standard curve to obtain the content of each genotoxic impurity in the to-be-measured solution. According to the method, various genotoxic impurities and dabigatran etexilate mesylate are effectively separated through a liquid-liquid extraction method, the influence of dabigatran etexilate on genotoxic impurity analysis is reduced, interfering substances are reduced, and the method is high in accuracy and good in repeatability.
Owner:BEIJING RESEARCH INSTITUTE OF CHEMICAL ENGINEERING AND METALLURGY

Analytical Method for Genotoxic Impurity of 2-Chloro-1,3-bis(dimethylamino)trimethylene hexafluorophosphate in Etoricoxib

The invention discloses an analysis method of 2-chloro-1,3-bis(dimethylamino)trimethylene hexafluorophosphate genotoxic impurities in etoricoxib, adopting an HPLC analysis method, wherein the following are adopted: the instrument is a high performance liquid chromatograph with an ultraviolet detector; mobile phase: A: phosphate and ion pair reagent buffer, B: methanol; gradient elution; detection wavelength: 310nm; column temperature: 30-40°C; injection volume: 10μl; solvent is: mobile phase A: B=30:70; test solution: concentration is 10mg / ml; reference solution: concentration is 0.125μg / ml; determination process: blank solution, reference solution and test solution are respectively sampled and analyzed in sequence; content is calculated by peak area according to an external standard method. The analysis method of the invention can be analyzed by conventional liquid chromatography method when the limit of genotoxic impurities in the drug is low, i.e., the determination is accurate, thereby reducing the detection cost.
Owner:无锡积大制药有限公司

Method for determining three methanesulfonate genotoxic impurities in prasefovir mesylate tablets by gas chromatography-mass spectrometry

The invention relates to a method for determining three methanesulfonate genotoxic impurities in a prasefovir mesylate tablet by gas chromatography-mass spectrometry, and belongs to the technical field of pharmaceutical analysis. The invention relates to a method for determining three methanesulfonate genotoxic impurities in prasefovir mesylate tablets by gas chromatography-mass spectrometry. The method comprises the following steps: (1) preparing three single-standard stock solutions, a mixed standard solution and a mixed standard series solution; (2) preparing a test solution; (3) rapid qualitative screening; and (4) quantitative determination. The gas chromatography-mass spectrometry method (GC-MS method) has remarkable advantages in the aspects of operation simplicity, specificity, sensitivity, accuracy and the like, the method is simple in operation process, sample pretreatment is easy to implement, the detection time is greatly shortened, and the detection efficiency is improved.
Owner:SHAANXI INST OF FOOD & DRUG INSPECTION

An analytical method for determining genotoxic impurities in nilotinib compositions

The present application belongs to the technical field of pharmaceutical analysis, and particularly relates to a kind of analytical method for determining genetic toxic impurities in nilotinib composition.The present application has good specificity, simple operation, high sensitivity, low cost, and is suitable for frequent detection in mass production, etc., for determining impurity A in compositions such as nilotinib oral suspension, nilotinib dry suspension or nilotinib capsules.The method can effectively separate the nilotinib impurity A peak from its adjacent impurity peak, and solve the problem of easy damage of the chromatographic column during the determination of nilotinib impurity A.
Owner:SHANDONG BESTCOMM PHARMA CO LTD